BI 69A11

Known as: BI-69A11 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
BI-69A11, novel Akt inhibitor, is currently drawing much attention due to its intriguing effect in inducing apoptosis in melanoma… (More)
Is this relevant?
2015
2015
Amplification of PI3K-Akt pathway promotes radioresistance in various cancers including colorectal carcinoma. Local recurrence in… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2014
2014
Background:Akt and its downstream signalling pathways contribute to the aetiology and progression of colorectal carcinoma (CRC… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2013
2013
To date, there are no effective therapies for tumors bearing NRAS mutations, which are present in 15-20% of human melanomas. Here… (More)
Is this relevant?
2011
2011
In melanoma, the activation of pro-survival signaling pathways, such as the AKT and NF-κB pathways, is critical for tumor growth… (More)
Is this relevant?
2009
2009
The AKT/PKB pathway plays a central role in tumor development and progression and is often up-regulated in different tumor types… (More)
Is this relevant?